Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overcoming obstacles in Parkinson's disease.
Sherer TB, Chowdhury S, Peabody K, Brooks DW. Sherer TB, et al. Mov Disord. 2012 Nov;27(13):1606-11. doi: 10.1002/mds.25260. Epub 2012 Oct 31. Mov Disord. 2012. PMID: 23115047 Review.
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
Dave KD, De Silva S, Sheth NP, Ramboz S, Beck MJ, Quang C, Switzer RC 3rd, Ahmad SO, Sunkin SM, Walker D, Cui X, Fisher DA, McCoy AM, Gamber K, Ding X, Goldberg MS, Benkovic SA, Haupt M, Baptista MA, Fiske BK, Sherer TB, Frasier MA. Dave KD, et al. Among authors: sherer tb. Neurobiol Dis. 2014 Oct;70:190-203. doi: 10.1016/j.nbd.2014.06.009. Epub 2014 Jun 24. Neurobiol Dis. 2014. PMID: 24969022 Free article.
Parkinson's disease is ready for precision medicine.
Sherer TB, Frasier MA, Langston JW, Fiske BK. Sherer TB, et al. Per Med. 2016 Sep;13(5):405-407. doi: 10.2217/pme-2016-0052. Epub 2016 Aug 9. Per Med. 2016. PMID: 29767601 No abstract available.
Special focus section: gene therapy for Parkinson's disease.
Fiske BK, Frasier MA, Sherer TB. Fiske BK, et al. Among authors: sherer tb. Exp Neurol. 2008 Jan;209(1):28-9. doi: 10.1016/j.expneurol.2007.09.006. Epub 2007 Sep 18. Exp Neurol. 2008. PMID: 17980867 No abstract available.
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits.
Baptista MAS, Merchant K, Barrett T, Bhargava S, Bryce DK, Ellis JM, Estrada AA, Fell MJ, Fiske BK, Fuji RN, Galatsis P, Henry AG, Hill S, Hirst W, Houle C, Kennedy ME, Liu X, Maddess ML, Markgraf C, Mei H, Meier WA, Needle E, Ploch S, Royer C, Rudolph K, Sharma AK, Stepan A, Steyn S, Trost C, Yin Z, Yu H, Wang X, Sherer TB. Baptista MAS, et al. Among authors: sherer tb. Sci Transl Med. 2020 Apr 22;12(540):eaav0820. doi: 10.1126/scitranslmed.aav0820. Sci Transl Med. 2020. PMID: 32321864
Biomarkers for Parkinson's disease.
Sherer TB. Sherer TB. Sci Transl Med. 2011 Apr 20;3(79):79ps14. doi: 10.1126/scitranslmed.3002488. Sci Transl Med. 2011. PMID: 21508309
Mechanism of toxicity in rotenone models of Parkinson's disease.
Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT. Sherer TB, et al. J Neurosci. 2003 Nov 26;23(34):10756-64. doi: 10.1523/JNEUROSCI.23-34-10756.2003. J Neurosci. 2003. PMID: 14645467 Free PMC article.
49 results